A series of 3-sulfenylazetidine derivatives 5a-f were synthesized via the ring-opening reactions of 1-azabicyclo[1.1.0]butane (ABB, 3) with thiols 4a-f in 50-92% yields. Treatment of ABB (3) with aromatic amines 9a-e and dibenzylamine (9f) in the presence of Mg(ClO 4 ) 2 afforded the corresponding 3-aminoazetidine derivatives 10a-f in 24-65% yields. N-Benzyl-3-bromoazetidine (13), which was obtained by the reaction of ABB (3) with benzyl bromide, gave 3-aliphatic amino-substituted azetidine derivatives 15a, b. Novel fluoroquinolones 7a-f, 11a-f, 16a, b and 25a-c were obtained by the introduction of these azetidine derivatives into the C7 position of a quinolone nucleus 6 and N1-heterocyclic quinolones 21a-c in 21-83% yields. Some of them exhibited a greater antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) in comparison with that of clinically used fluoroquinolone, levofloxacin (LVFX).
Although 1-azabicyclo[1.1.0]butane (ABB, 3) proved to be the unique molecule bearing the highly strained bicyclic structure, little attention has been paid to the unusual ring system. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Specifically, the synthetic utility of ABB (3), which must be useful for the preparation of various 1,3disubstituted and 3-monosubstituted azetidines, 1, 9, 10) has scarcely reported because of its synthetic difficulty due to the remarkably strained structure. These azetidine moieties have often been found in many natural products 11) and biologically active compounds such as carbapenems 1) and new quinolone antibiotics. [12] [13] [14] [15] 1,3,3-Trinitroazetidine (TNAZ), 16, 17) an insensitive high explosive, was also synthesized by using ABB (3) . In recent years, we established an efficient method for synthesis of ABB (3) starting from allylamine (1) via 2,3-dibromopropylamine hydrobromide (2) , and reported its application to the synthesis of several azetidine derivatives, as shown in Chart 1. 9) We also reported a practical synthesis of 1-(1,3-thiazolin-2-yl)azetidine-3-thiol as the fascinating pendant moiety of a new oral 1b-methylcarbapenem antibiotic, L-084 by starting from ABB (3) . 1) This expeditious construction method for 3-monosubstituted azetidine derivatives employing ABB (3) seemed to be useful also for developing new quinolone antibiotics.
Fluoroquinolones have been developed and are widely used clinically. This is because they have potent, a broad spectrum of antibacterial activities, and few side effects. [18] [19] [20] [21] [22] However, increasingly multidrug-resistant pathogens, especially methicillin-resistant Staphylococcus aureus (MRSA), have become a serious problem particularly during the last decade. 23) The resistance levels to quinolones are as yet relatively low but are steadily increasing. 24) Therefore new antibacterial agents have become increasingly urgent. This prompted us to develop new quinolones utilizing the azetidine derivatives, in which the C7 substituents of fluoroquinolone carboxylic acids play important antibacterial roles. [18] [19] [20] [21] [22] Previously, we communicated synthesis and antibacterial activities of new quinolone derivatives utilizing ABB (3) . 10) We now describe, in detail, a convenient method of synthesizing several 3-sulfenyl-and 3-aminoazetidine derivatives utilizing ABB (3) , and we discuss the synthesis and antibacterial activities of new quinolone antibiotics incorporating these azetidine derivatives to the C7 position. Although several examples of 7-azetidinylquinolones have been reported, [12] [13] [14] [15] there have been not many prominent quinolone antibiotics bearing the azetidinyl substituent groups thus far. We envisaged that the introduction of azetidine derivatives onto the C7 position of the quinolone nucleus might enhance their antibacterial activities against MRSA.
Results and Discussion
A tetrahydrofuran (THF) solution of ABB (3), obtained by treatment of 2,3-dibromopropylamine hydrobromide (2) with n-BuLi at Ϫ78°C in THF followed by codistillation with THF, 1) was employed for the synthesis of 3-sulfenyl-and 3amino azetidine derivatives 5a-f and 10a-f. 10) The synthesis of the fluoroquinolones bearing 3-sulfenylazetidine derivatives was performed in a following manner. Namely, the ring-opening reaction of small excess ABB (3) with several heterocyclic thiols 4a-e and p-toluenethiol (4f) was carried out in THF at room temperature. The reaction proceeded smoothly to furnish the desired corresponding 3-sulfenylazetidine derivatives 5a-f in 50-92% yields, as shown in Table 1 . Compounds 5c-f were purified as the hydrochlorides by treatment of the crude products with 2 N HCl in Et 2 O because of their instability during chromatographic purifica-tion on a silica gel column. The structures of 3-sulfenylazetidine derivatives 5a-f were determined by their characteristic 1 H-NMR spectra and high-resolution MS analysis (see Experimental). In all the sulfenylation reactions, ABB (3) must play an important role as a base [e.g., 3-phenyl-1-azabicyclo[1.1.0]butane: pK a (H 2 O)ϭ7.3, benzenethiol: pK a (H 2 O)ϭ6.6] 7, 25) to heterocyclic thiols and benzenethiols. The resulting anionic thio group can smoothly attack the C3 position of ABB (3) followed by cleavage of the highly strained N1-C3 s-bond to furnish each corresponding 3sulfenylazetidine derivative. Subsequently, we chose readily accessible compound 6 as a quinolone nucleus, obtained from the Grohe-Heitzer reaction procedure [26] [27] [28] [29] [30] employing 2,3,4,5-tetrafluorobenzoic acid and cyclopropyl amine, because the cyclopropyl group was widely used as an N1 substituent for the quinolone antibiotics, which generally provided wide and potent antibacterial activities. 22) The compound 6 was treated with 3-sulfenylazetidine derivatives 5a-f in the presence of 1,4-diazabicyclo[2.2.2]octane (DABCO) in MeCN under reflux to give the corresponding 7-(3-sulfenylazetidin-1-yl)fluoroquinolone carboxylic acids 7a-f in 21-66% yields ( Table 1 ). The structure of product 7b was precisely determined by X-ray crystallographic analysis ( Fig. 1 ). 31) Other products were shown to be structures 7a and 7c-f, based on the spectroscopic and elemental analyses in comparison with those of 7b.
To determine the azetidine ring's effect on antibacterial activity in comparison with that of 7a, sulfenyl-C7-substituted fluoroquinolone 8 was prepared by similar treatment of the compound 6 with 5-mercapto-1-methyltetrazole (4a) in the presence of DABCO in MeCN under reflux, as shown in Chart 2.
Subsequently, we attempted the similar ring-opening reaction of ABB (3) with aniline (9a) without an additive to the case of thiols 4a-f, but the desirable reaction did not proceed even under the reflux conditions. Then, we tried activation of ABB (3) with Brønsted acids (CSA, TFA) in the presence of aniline (9a), but an unknown polymer was obtained instead of the desired 3-anilinoazetidine (10a). Thus, we examined in detail the ring-opening reaction of ABB (3) with aniline (9a) in the presence of various Lewis acids, as shown in Table 2 .
When BF 3 · OEt 2 or trimethylsilyl trifluoromethanesulfonate (TMSOTf) was employed, a polymer was formed together with 3-anilinoazetidine (10a) in 29 or 38% yield (Entries 1, 2). The similar reaction was attempted using Zn(OTf) 2 in THF at 0°C for 1 h to give 3-anilinoazetidine (10a) in 61% yield (Entry 3). However, the results using other Lewis acids such as Mg(ClO 4 ) 2 , Mg(OTf) 2 , Cu(OTf) 2 , Yb(OTf) 3 , Hf(OTf) 4 , Zn(ClO 4 ) 2 · 6H 2 O, and LiClO 4 were not improved (Entries 4-10). Lewis acids having chloride anion such as MgCl 2 , TiCl 4 , and AlCl 3 decreased the yield of 10a as opposed to the case of Zn(OTf) 2 or Mg(ClO 4 ) 2 (Entries 3, 9, [11] [12] [13] . After detailed investigation, Mg(ClO 4 ) 2 was shown to be relatively suitable for the ring-opening reactions of ABB (3) with aniline (9a). Thus, we chose Mg(ClO 4 ) 2 as the additive for the ring-opening reaction of ABB (3) with several amines because of its good solubility in THF, fewer by-products, and low cost. A small amount of excess ABB (3) was allowed to react with aromatic amines 9a-e and dibenzylamine (9f) in the presence of 2.0 mol eq of Mg(ClO 4 ) 2 in THF at 0°C for 3-24 h to furnish the corresponding 3-aromatic aminoazetidines 10a-e in 24-53% yields and 3-dibenzylaminoazetidine (10f) in 38% yield, respectively, as shown in Table 3 . When the ring-opening reaction was carried out employing a reduced amount (1.2 mol eq) of Mg(ClO 4 ) 2 and MeCN as a cosolvent, the yields of 10a, b were improved (10a: 65% yield, 10b: 61% yield). Unfortunately, the ring opening reaction of ABB (3) with aliphatic amines in the presence of Mg(ClO 4 ) 2 resulted in production of an unknown polymer. The structures of 10a-f were assigned by their characteristic 1 H-NMR spectra and other spectroscopic analyses (see Experimental) . Then, compounds 10a-f were treated with compound 6 in the presence of DABCO in MeCN under reflux to afford the corresponding 7-(3-aminoazetidinyl)fluoroquinolone carboxylic acids 11a-f in 62-83% yields, as shown in Table 3 . The structures of 11a-f were assigned by the spectroscopic and elemental analyses in comparison with those of 7b.
The reaction of ABB (3) with cyclic aliphatic amines was investigated as follows. Since the desirable reaction did not proceed under the same conditions as described in Table 3 , we focused on N-benzyl-3-bromoazetidine (13) 8) which can be exploited to synthesize various azetidine derivatives via suitable nucleophilic substitution reaction. The compound 13 was obtained via two steps of reactions involving the ringopening reaction of ABB (3) with HBr to give 3-bromoazetidine hydrobromide (12) followed by benzyl protection of the N1 group, but this reaction procedure resulted in a low yield (24% total yield). We carefully examined the reaction conditions to obtain 13 from ABB (3) by one step of reaction. Thus, treatment of ABB (3) with benzyl bromide under reflux afforded the desired compound 13 in 61% yield (Chart 3).
Several reactions of 13 with pyrrolidine were carried out in the presence of various bases in some solvents under reflux, as shown in Table 4 . We realized that K 2 CO 3 was a good reagent for this substitution reaction (Entry 4) in comparison with other bases (Entries 1 -3, 5) . Based on screening the reaction solvents, MeCN seemed to be suitable (Entries 4, (6) (7) (8) .
Thus, compounds 14a, b were subjected to hydrogenolysis of the benzyl group on Pd(OH) 2 /C to give 15a, b, which were 348
Vol. 56, No. 3 allowed to react with 6 to afford the corresponding 7-azetidinyl quinolones 16a, b in 61% yield from 14a and in 63% yield from 14b, respectively, as shown in Chart 4. The structures were shown to be 16a, b on the basis of their spectroscopic data. Kuramoto et al. reported that the potency order of C7 substituent for 1-cyclopropyl quinolones was as follows: pyrrolidineϾpiperazine, azetidine. 32) On the other hand, the order for 1-aminodifluorophenyl and 1-aminodifluoropyridyl quinolones was reverse to that for 1-cyclopropyl quinolones: azetidineϾpiperazine, pyrrolidine. 32) In addition, 1-aminodifluorophenyl and 1-aminodifluoropyridyl quinolones caused mild phototoxicity, despite the substitution of a halogen atom at the C8 position. 33) Therefore, we attempted syntheses of N1-heterocyclic quinolones, as shown in Chart 5. Namely, 2,3,4,5-tetrafluorobenzoic acid 17 was converted to the known compound 19 via b-keto ester 18 by exploiting known reactions. 34) The crude product 19 was treated with various amines, such as 2-aminothiazole, 2-aminopyrimidine, 4amino-1-methylcytosine, and benzylamine in EtOH or CH 2 Cl 2 to give the corresponding enamines 20a-d. Treatment of the crude enamines 20a-d with K 2 CO 3 in N,N-dimethylformamide (DMF) afforded cyclized products 21a-d in 43-63% yields. Hydrolysis of 21a-c in 6 N HCl and AcOH at 100°C gave the corresponding carboxylic acids 22a-c in 67-95% yields. Reaction of 22a-c with 3-(4-methoxyanilino)azetidine (10b) in the presence of DABCO in MeCN under reflux afforded decarboxylated products 23a-c in 54-83% yields. This easy decarboxylation outcome of 22a-c can be explained in terms of fairly strong electron-withdrawing effect of the heterocyclic N1 moiety. Although we attempted the nucleophilic substitution reactions of 22a-c without decarboxylation by derivatizing to their boron difluoride intermediates or by the method in the presence of LiCl, 15) desirable products 25a-c have never been obtained. On the other hand, treatment of 21a-c with 3-(4-methoxyanilino)azetidine (10b) at room temperature or 40°C in MeCN afforded 7-azetidinylquinolone ethyl esters 24a-c in 56-78% yields. Alkaline hydrolysis of 24a-c followed by acidification with AcOH provided the desired N1-heterocyclic-7-azetidinyl quinolones 25a-c in 48-80% yields, as shown in Chart 5.
Since any quinolone antibiotic bearing the sulfonamide or carbamate moiety at the N1 position has been unknown, we have done such an attempt as follows. The benzyl (Bn) group of compound 21d (see Chart 5) was removed by hydrogenolysis on Pd/C at room temperature to give compound 26 in 98% yield. Treatment of 26 with p-toluenesulfonyl chloride, methanesulfonyl chloride, N,N-dimethylsulfamoyl chloride, and ethyl chloroformate gave compound 27a-d in 54%quantitative yields instead of N1-substituted products 28ad, as shown in Chart 6.
The structure of product 27a was precisely determined by X-ray crystallographic analysis, as represented in Fig. 2 . Other products 27b-d were determined as the aromatized quinoline structures based on their spectroscopic analyses in comparison with those of 27a. 35) The minimum inhibitory concentrations (MICs) of the synthesized compounds 7a-f, 8, and 11a, f against several representative Gram-positive and Gram-negative bacteria utilizing a conventional agar dilution procedure 36) are listed in Table 5 , along with the data for levofloxacin (LVFX) for comparison. 37, 38) The compounds 7a-f bearing 3-sulfenylazetidines as the C7 substituent of 6 exhibited moderate antibacterial activities against each species of bacteria. The antibacterial activities (except for those against Escherichia coli) of 7a, b and 7e are somewhat potent among the 7-(3-sulfenylazetidin-1-yl)fluoroquinolone series compounds 7a-f. The antibacterial activities of 7e against methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA species (S. aureus 1-4 in Table 5 ), some of which have amino acid mutation in GyrA of DNA gyrase and ParC of topoisomerase IV, were shown to be superior to those of LVFX. However, its activity against Gram-negative bacteria (except for Haemophilus influenzae) was low. Compound 7a, bearing the 3-(1-methyltetrazol-5-yl)thioazetidine moiety at the C7 position of the fluoroquinolone carboxylic acid 6, exhibited more potent activities against Gram-positive bacteria than those of compound 8 bearing the (1-methyltetrazol-5-yl)thio group alone without the azetidine moiety. Compounds 7a, b and 8 were affected by AcrAB, an efflux system of Escherichia coli, which seemed to be changeable by the basicity of the substituent groups at the C7 position. While 7-(3-anilinoazetidin-1-yl)fluoroquinolone carboxylic acid 11a displayed fairly potent antibacterial activities against Gram-positive bacteria, compound 11f, having a large substituent at the C3 position of the azetidine ring, exhibited remarkably reduced activities.
Because 11a exhibited significantly potent activities against Gram-positive bacteria ( Table 5 ), compounds 11a-e together with LVFX were subjected to the antibacterial screening test, as shown in Table 6 . The test results showed that the antibacterial spectra of 11a-e do not differ much and that the effects of mutation as well as those of the efflux system seem to be similar among these antibiotics. However, their potencies differed only slightly. Compound 11b exhibited four-fold better activity against Staphylococcus pneumoniae (S. pneumoniae R6 and 3-7 in Table 6 ), such as penicillin-susceptible Staphylococcus pneumoniae (PSSP) and penicillin-resistant Staphylococcus pneumoniae (PRSP) having amino acid mutation in GyrA and ParC, than 11a. Compounds 11a-e were more potent than LVFX against quinolone-susceptible and -intermediate MRSA (S. aureus 1 and 3 in Table 6 ). These compounds did not show considerable antibacterial activities against quinolone-resistant MRSA (S. aureus 4) or Pseudomonas aeruginosa, as shown in Table 6 . Compounds 16a, b and 25a-c together with 11b and LVFX were subjected to the antibacterial screening test, as shown in Table 7 . The compounds 16a, b exhibited comparable antibacterial activities with those of LVFX against both Gram-positive and Gram-negative bacteria. The antibacterial activities of 16a, b seemed to be similar to those of 11b against Gram-negative bacteria and to be 4-64 times lower than those of 11b against Gram-positive bacteria. On the other hand, N1-heterocyclic quinolones 25a-c did not show activities. In conclusion, this work demonstrated a convenient synthesis of 3-sulfenylazetidine derivatives 5a-f and 3aminoazetidine derivatives 10a-f utilizing ABB (3) . N-Benzyl-3-bromoazetidine (13) was readily prepared by treatment of 3 with benzyl bromide, and exploited for the synthesis of 3-pyrrolidine and 3-piperidine-substituted azetidine derivatives 15a, b. Several azetidine derivatives were successfully introduced into fluoroquinolone carboxylic acid 6 to give the corresponding fluoroquinolone antibiotics 7a-f, 11a-f,  and 16a, b . Most of the series of fluoroquinolones exhibited more potent activity profiles versus Gram-positive bacteria than versus Gram-negative bacteria. In particular, compounds 11a-e exhibited the fairly potent activities against quinolone-susceptible and intermediate MRSA in comparison with the activities of a clinically used fluoroquinolone, LVFX. Although we synthesized 7-azetidinylquinolones 25a-c bearing N1-heterocyclic groups, their antibacterial activities were remarkably weak.
Experimental
All melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected. IR spectra were recorded on a JASCO FT/IR-420 IR Fourier transform spectrometer. 1 H-NMR spectra were recorded on a JEOL JNM-AL300 (300 MHz) or JEOL JNM-AL400 (400 MHz) spectrometer. 13 C-NMR spectra were recorded on a JEOL JNM-AL300 (75 MHz) or JEOL JNM-AL400 (100 MHz) spectrometer with complete proton decoupling. Chemical shifts are given in d values (ppm) using tetramethylsilane (TMS) as an internal standard. Electron impact (EI)-MS and FAB-MS were recorded on a JEOL JMS SX-120A spectrometer. Electron spray ionization (ESI)-MS were recorded on a Waters LCT Premier spectrometer. Elementary combustion analyses were determined by a Yanaco CHN CORDER MT-5. All reactions were monitored by TLC employing 0.25-mm silica gel plates (Merck 5715; 60 F 254 ). Column chromatography was carried out on silica gel [Kanto Chemical 60N (spherical, neutral); 63-210 mm] or basic alumina (Merck 1076; 90 active basic). X-Ray crystal structure data were collected using a Rigaku RAXIS-RAPID diffractometer. All reagents were used as purchased.
Procedure (A) for the Preparation of 3-Sulfenylazetidines 5 To a solution of 5-mercapto-1-methyltetrazole (4a, 141.1 mg, 1.21 mmol) in THF (5 ml) was added dropwise ABB (3, ca. 0.1 mol/l in THF, 14.5 ml, ca. 1.45 mmol) 1) at Ϫ5°C. After being stirred at room temperature for 24 h, the reaction mixture was evaporated in vacuo to give an oily residue, which was purified by column chromatography on silica gel with CHCl 3 -MeOH (10 : 1, v/v) to afford 5a (173.0 mg, 83%) as a colorless oil.
3-(1-Methyltetrazol-5-yl)thioazetidine (5a) 32.11, 32.13, 41.0, 54.9, 147.6, 151 .0; EI-MS Calcd for C 6 H 10 N 4 S MW 170.0626, Found m/z 170.0615 (M ϩ ).
Procedure (B) for the Preparation of 3-Sulfenylazetidines 5
To a solution of 2-mercaptobenzothiazole (4c, 203.6 mg, 1.22 mmol) in THF (5 ml) was added dropwise ABB (3, ca. 0.1 mol/l in THF, 14.5 ml, ca. 1.45 mmol) 1) at Ϫ5°C. After being stirred at room temperature for 24 h, the reaction mixture was added dropwise to 2 N HCl in Et 2 O at 0°C with stirring. The precipitate was collected by filtration and washed subsequently with THF, CHCl 3 , and Et 2 O to afford 5c (204.2 mg, 65%) as a white powder.
3-(Benzo[b]thiazol-2-yl)thioazetidine Hydrochloride (5c): White powder (MeOH), mp 124-125.5°C; 1 H-NMR (400 MHz, CD 3 OD) d: 4. 25-4.40 (m, 2H), 4.58-4.77 (m, 2H), 4.82-4.91 (m, 1H), 7.32-7.56 (m, 2H), 7.86-7.97 (m, 2H ); 13 C-NMR (75 MHz, CD 3 OD) d: 37.9, 53.5, 122.5, 122.7, 126.0, 127.5, 136.3, 154.1, 164.7; IR (KBr) 7.53-7.71 (m, 2H) ; 13 C-NMR (75 MHz, CD 3 OD) d: 36.7, 53.2, 111.2, 119.7, 125.9, 126.0, 142.6, 153.1, 163.2; IR (KBr) 2855, 1600, 1504, 1454 cm Ϫ1 ; FAB-MS Calcd for C 10 H 11 N 2 OS MW 207.0604, Found m/z 207.0592 (M ϩ ϪCl).
3-(Pyrimidin-2-yl)thioazetidine Hydrochloride (5e): Pale yellow powder (MeOH); mp 118-120°C (dec.); 1 H-NMR (400 MHz, CD 3 OD) d: 4. 11-4.29 (m, 2H), 4.54-4.74 (m, 3H), 7.21-7.30 (m, 1H), 8.60-8.66 (m, 2H) ; 13 
